000 04341cam a22003854a 4500
005 20250918143942.0
008 110819s2010 enk b 001 0 eng
020 _a9780521116565 (hardback)
_cRM366.93
020 _a0521116562 (hardback)
039 9 _a201206191432
_badnan
_c201205091331
_dmasrul
_c201204251402
_dmasrul
_y08-19-2011
_zmasrul
040 _aDNLM/DLC
_cDLC
_dYDX
_dNLM
_dUKM
_dBTCTA
_dYDXCP
_dBWK
_dCDX
_dBWX
_dUTO
_dDLC
_dUKM
090 _aC59.25.I536 2
090 _aC59.25
_b.I536 2
245 0 0 _aIncentives for global public health :
_bpatent law and access to essential medicines /
_cedited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein.
260 _aCambridge, UK :
_bCambridge University Press,
_c2010.
300 _axxi, 512 p. ;
_c24 cm.
490 0 _aConnecting international law with public law
504 _aIncludes bibliographical references and index.
505 0 _aIntroduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein --TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss --The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng --The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod.
520 _a'This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of'creative capitalism''--Provided by publisher.
650 0 _aPharmaceutical policy.
650 0 _aPatent laws and legislation
650 0 _aDrugs
_xPatents.
650 0 _aPatents (International law)
700 1 _aPogge, Thomas Winfried Menko.
700 1 _aRimmer, Matthew.
700 1 _aRubenstein, Kim.
907 _a.b15141019
_b2021-05-28
_c2019-11-12
942 _c01
_n0
_kC59.25.I536 2
914 _avtls003477066
990 _amab
991 _aFakulti undang-Undang
998 _au
_b2011-06-08
_cm
_da
_feng
_genk
_y0
_z.b15141019
999 _c498380
_d498380